Testing effectiveness (Phase 2)Study completedNCT00217399
What this trial is testing
Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
Who this might be right for
Recurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 35